OphthalmologyIND Stage

Diabetic RetinopathyAVD-302

Aviceda’s high affinity ligands engage with immune modulatory receptors on immune cells to diminish the activation and release of inflammatory mediators, inhibit NETosis, and other destructive pathways, and thereby decrease the biochemical drivers of diabetic retinopathy.

Background image Ophthalmology Geographic Atrophy - AVD-104

Ophthalmology Geographic Atrophy - AVD-104

Background image Ophthalmology Diabetic Macular Edema - AVD-104

Ophthalmology Diabetic Macular Edema - AVD-104

Background image Ophthalmology Diabetic retinopathy - AVD-302

Ophthalmology Diabetic retinopathy - AVD-302

Background image Fibrosis Myelofibrosis

Fibrosis Myelofibrosis

Background image Inflammation Lung inflammation

Inflammation Lung inflammation

Background image Neuroinflammation CNS injury

Neuroinflammation CNS injury

Background image Oncology Solid tumors

Oncology Solid tumors